Slide 1: FY2011 (6/10-5/11) Results Explanatory Meeting
FY2011 (6/10-5/11) Results Explanatory Meeting July 15, 2011 The earnings forecasts appearing in this material are based on the business environment at the present time, and there is the possibility that actual earnings may differ from forecasts for various reasons. Furthermore, only inquiries in Ja
Slide 2: FY2011 Consolidated Results
FY2011 Consolidated Results 2
Slide 3: 1. FY2011 Consolidated Profit and Loss Statement
1. FY2011 Consolidated Profit and Loss Statement FY2010 results FY2011 results (consolidated) (consolidated) Share Share YoY change % of projection (million yen) (million yen) (%) (%) (%) (%) Net sales 149,081 100.0 154,875 100.0 103.9 98.5 Gross profit 38,713 26.0 41,627 26.9 107.5 99.5 SG&A expens
Slide 4: 2. FY2011 Consolidated Balance Sheet
2. FY2011 Consolidated Balance Sheet Main Maincauses causesof ofchange change (million yen) May 31, 2010 May 31, 2011 Total Change Totalassets assets Cash (consolidated) (consolidated) Cashand andmarketable marketablesecurities securities (negotiable (negotiable certificatesofof certificates deposit
Slide 5: 3. FY2011 Consolidated Statement of Cash Flows
3. FY2011 Consolidated Statement of Cash Flows Breakdown Breakdown (million yen) FY2010 FY2011 Change (consolidated) (consolidated) Net Netprofit profitbefore beforetaxes taxes 8,018 8,018million millionyen yen Depreciation expenses 1,999 million yen Depreciation expenses 1,999 million yen Cash flow
Slide 6: 4. Main business indicators (industry ranking)
4. Main business indicators (industry ranking) Recurring profit margin Return on assets Return on equity 社名 実績 社名 実績 社名 実績 CREATE SD CREATE SD COSMOS 1 5.6％ 1 HOLDINGS 14.7％ 1 Pharmaceutical 21.2％ HOLDINGS CREATE SD 2 SUNDRUG 5.5％ 1 SUNDRUG 14.7％ 2 HOLDINGS 14.8％ TSURUHA COSMOS 2 5.5％ 3 Pharmaceutic
Slide 7: Results for Each Business Company
Results for Each Business Company 7
Slide 8: 1. FY2011 Profit and Loss Statement (Create SD)
1. FY2011 Profit and Loss Statement (Create SD) Projections Projectionswere wereachieved achievedand andsales salesand andprofits profitsrose rosedue dueto toan animprovement improvementininthe thegross grossprofit profit margin (+1.0 percentage point compared to the previous year) and success in re
Slide 9: 2. Sales
2. Sales Create SD For Forexisting existingstores, stores,sales salesfell fell1.9%, 1.9%,number numberof ofcustomers customers2.2%, 2.2%, and and average spending per customer 0.2% compared to theprevious average spending per customer 0.2% compared to the previousyear. year. Upward Upwardtrend trend
Slide 10: 3. Gross Profit
3. Gross Profit Create SD Gross Grossprofit profitmargin marginimproved improved1.0 1.0percentage percentagepoint pointcompared comparedto tothe theprevious previousyear yearto to26.9%. 26.9%. Declined for the medical and health products segment since inventory of masks was disposed of but improved
Slide 11: 4. SG&A Expenses
4. SG&A Expenses Create SD SG&A SG&Aexpense expenseratio ratiorose roseto to21.7% 21.7%from from21.4% 21.4%but butwas wasininline linewith withprojections. projections. SG&A expenses were 1,000 million yen (3.0%) less than forecast. SG&A expenses were 1,000 million yen (3.0%) less than forecast. Mon
Slide 12: 5. New Store Openings
5. New Store Openings Create SD 31 31new newstores storeswere wereopened opened(of (ofwhich which44were werededicated dedicatedprescription prescriptionpharmacies) pharmacies) Store openings by area Figures in parenthesis are dedicated prescription pharmacies Kanagawa Tokyo Shizuoka Saitama Chiba Gu
Slide 13: 6. Prescription Operations
6. Prescription Operations Create SD AAtotal totalof of49 49stores storesat atthe theend endof ofthe the 88new newstores storeswere wereopened opened fiscal year (4(4dedicated fiscal year dedicatedprescription prescriptionpharmacies pharmaciesand and44in- in- (17 (17dedicated dedicatedprescription p
Slide 14: 7. Fee-charging Nursing Home and Preventive Nursing Business
7.Fee-charging Nursing Home Welllife and Preventive Nursing Business FY2011 results Share % of projection (million yen) (%) (%) Net sales 780 100.0 106.3 Operating profit 63 8.1 33.2 Recurring profit 66 8.6 35.6 Net profit -7 -0.9 － * The income statement is based on the simple addition of figures f
Slide 15: Growth Strategy
Growth Strategy CREATE SD HOLDINGS
Slide 16: 1. Growth Strategy – Drug Store Operations
1. Growth Strategy – Drug Store Operations Accelerate Acceleratethe theopening openingof ofnew newstores storeswith withthe thegoal goalof ofcreating creatingaanetwork networkof of450 450stores stores during FY2014 during FY2014 Strive Striveto toopen open40 40new newstores storesduring duringcurren
Slide 17: 2. Growth Strategy – Prescription Operations
2. Growth Strategy – Prescription Operations The Themission missionof ofaadrug drugstore storeisisto tocontribute contributeto tomedical medicaland andnursing nursingcare carein inthe the local localcommunity. community. Create CreateSD SDwill willbecome becomeaacompany companythat thatfirmly firmly
Slide 18: 3. Growth Strategy – Nursing Operations
3. Growth Strategy – Nursing Operations Expand Expandrehabilitative rehabilitativetraining trainingday dayservices services → →Open Open2020new newfacilities facilitiesthis thisyear year Rehabilitation Rehabilitationday dayservices services Strength ＋ Dementia ＋ Psychological care training preventio
Slide 19: 4. Create Group Medium-term Vision
4. Create Group Medium-term Vision Creating Creatingaasystem systemto tocontribute contributeto tosociety societyas asaacomprehensive comprehensivehealthcare healthcare support supportcompany companyinincooperation cooperationwith withcommunity communitymedical medicalfacilities facilities Operation
Slide 20: Net sales and recurring profit / Number of stores
Net sales and recurring profit Bar graph: Net sales Graph: Recurring profit (million yen) (million yen) million yen million yen million yen million yen FY 2007 FY 2008 FY 2009 FY 2010 FY 2011 FY 2012 FY 2014 （ projection ） （ projection ） Number of stores Total for OTC stores and dedicated prescripti
Slide 21: FY2012 Projections (Consolidated)
FY2012 Projections (Consolidated) FY2011 FY2012 (consolidated results) (consolidated projection) Share Share YoY Change (million yen) (million yen) (%) (%) (%) Net sales 154,875 100.0 166,445 100.0 107.5 Gross profit 41,627 26.9 43,864 26.4 105.4 SG&A expenses 33,184 21.4 35,946 21.6 108.3 Operating
Slide 22: FY2012 Projections (Create SD – Drug Stores and Prescription Operations)
FY2012 Projections (Create SD – Drug Stores and Prescription Operations) FY2011 FY2012 (results) (projection) Share Share YoY change (million yen) (million yen) (%) (%) (%) Net sales 154,094 100.0 165,222 100.0 107.2 Gross profit 41,516 26.9 43,841 26.5 105.6 SG&A expenses 33,422 21.7 36,275 22.0 10
Slide 23: FY2012 Projections (Fee-charging Nursing Home and Preventive Nursing Business)
FY2012 Projections (Fee-charging Nursing Home and Preventive Nursing Business) FY2011 FY2012 (results) (projection) Share Share YoY change (million yen) (million yen) (%) (%) (%) Net sales 780 100.0 1,222 100.0 156.6 Operating profit 63 8.1 -36 － － Recurring profit 66 8.6 -42 － － Net profit -7 -0.9